DIAGNOSTICS
Otoacoustic Emissions
What are they and why are they important?
By Joe Saliba, MD | Neuro-otologist and Skull Base Surgeon
Discover the science behind otoacoustic emissions and why they play a crucial role in auditory health.
Understanding Otoacoustic Emissions: The Basics
Otoacoustic emissions, often abbreviated as OAEs, are sounds that are produced by the inner ear (specifically the outer hair cells of the cochlea) either spontaneously or in response to an auditory stimulus. These soft sounds generated can be detected and measured. Think of OAEs as echoes produced by a healthy inner ear.
The presence of these emissions can be detected with a special microphone placed in the ear canal. OAEs are a crucial part of our auditory system and serve as an important diagnostic tool for assessing hearing health.
How Otoacoustic Emissions Are Measured
Measuring otoacoustic emissions involves a non-invasive, pain-free and quick procedure. During the test, a small probe is placed in the ear canal. This probe contains both a speaker, which emits sounds into the ear, and a microphone, which picks up the emissions produced by the cochlea in response.
Types of Otoacoustic Emissions
There are two primary types of OAE tests:
1. Spontaneous otoacoustic emissions (SOAEs):
- Not measurable when hearing loss exceeds 20-25 dB HL
2. Evoked otoacoustic emissions (EOAEs):
EOAEs are heard in responses to auditory stimulation that is done with the probe that we insert in the ear. There are 2 main types of evoked OAEs:
- Transient Evoked OAEs (TEOAEs): These are produced in response to brief acoustic stimuli, typically clicks or tone bursts. TEOAEs are like quick echoes from the cochlea.
- Advantages:
- Faster to administer, especially for screening purposes
- Better for low-frequency hearing (1000-4000 Hz)
- More robust in infants and young children
- Better for overall cochlear health assessment
- Clinical use
- Newborn hearing screening (fastest method)
- Detecting mild to moderate hearing loss
- Monitoring ototoxicity
- Advantages:
-
- Limitations:
- Not measurable when hearing loss exceeds 25-35 dB HL
- Less frequency-specific than DPOAEs
- May be affected by middle ear status
- Less sensitive to high-frequency hearing loss
- Limitations:
- Distortion Product OAEs (DPOAEs): These occur when two pure tones at two separate frequencies (f1 and f2) are presented simultaneously. The cochlea responds by producing a third tone at a specific frequency. The frequency range tested can go up to 8000 Hz. The other advantage is that it provides us with more specific answers as to which frequency is affected (as opposed to transient OAEs which are not as specific).
- Advantages:
- Better for assessing specific frequencies, especially high frequencies (4000 Hz and above)
- More sensitive for detecting subtle changes in cochlear function
- More resilient to hearing loss
- Preferred for ototoxicity monitoring
- Clinical use:
- Assessing cochlear function across a wide frequency range
- Detecting high-frequency hearing loss
- Ototoxicity monitoring
- Evaluating challenging-to-test patients
- Advantages:
-
- Limitations:
- Not measurable when hearing loss exceeds 40-50 dB HL
- More complex to interpret than TEOAEs
- May be affected by standing waves in the ear canal
- Requires longer test time for low frequencies
- Limitations:
Clinical Implications of Otoacoustic Emissions in Hearing Health
Otoacoustic emissions play a vital role in monitoring and diagnosing hearing health. Because OAEs are generated by the outer hair cells in the cochlea, their presence indicates that these cells are functioning properly. This makes OAE testing an essential tool in detecting hearing impairments, especially those caused by issues within the cochlea.
OAE tests can help identify hearing loss at an early stage, even before it becomes noticeable to the individual. This early detection is crucial for prompt intervention and management, which can significantly improve outcomes for those with hearing impairments.
Understanding these limitations of each OAE type is crucial for interpreting the results:
- Screening: For newborn hearing screening, the presence of OAEs generally indicates hearing thresholds better than 30-35 dB HL.
- Diagnostics: The absence of OAEs suggests a hearing loss greater than 25-35 dB HL for TEOAEs and 40-50 dB HL for DPOAEs, depending on the frequency.
- Ototoxicity Monitoring: DPOAEs are preferred due to their ability to be measured in the presence of more hearing loss and at higher frequencies.
- Difficult-to-Test Patients: In cases where behavioral audiometry is challenging, the presence or absence of OAEs can provide valuable information about cochlear function and approximate hearing thresholds.
Otoacoustic Emissions in Newborn Hearing Screening
One of the most critical applications of otoacoustic emissions is in newborn hearing screening. Early detection of hearing loss in infants is vital for their language, social, and cognitive development. OAE testing is often used in hospitals as part of routine newborn screening programs because it is quick, safe, and effective.
By identifying hearing issues early, healthcare providers can ensure that appropriate interventions, such as hearing aids or cochlear implants, are provided in a timely manner. This early intervention can help mitigate the impact of hearing loss on a child's development and quality of life.
Future Implications and Research in Otoacoustic Emissions
Research in the field of otoacoustic emissions is ongoing, with the aim of improving diagnostic techniques and expanding our understanding of auditory health. Future advancements may lead to more precise and comprehensive hearing assessments, as well as new treatments for hearing impairments.
Innovations in OAE technology could also enhance the ability to monitor hearing health over time, providing valuable insights into the progression of hearing disorders and the effectiveness of various interventions. As research continues, the potential applications of OAEs in both clinical and research settings are likely to grow, offering new hope for individuals with hearing loss.
Joe Saliba, MD
Dr. Joe Saliba is an ENT surgeon specialized in neuro-otology and medical director at ODYO. He treats patients with various ear and skull base disorders, ranging from hearing loss and vertigo to vestibular schwannomas and cochlear implants.
A hearing test conducted by an audiologist is the first step towards achieving good hearing.
ODYO partners with audiology clinics to conduct comprehensive hearing assessments and create personalized intervention plans, specifically tailored to meet each patient's unique communication and hearing care needs.